Today’s Technician: Heatstroke in Dogs
Brandy Tabor, CVT, VTS (ECC)
This life-threatening condition can affect dogs of any age, breed, or gender. The author provides guidance on the types of heatstroke, risk factors, pathophysiology, diagnosis, treatment therapies, and prevention.
Heatstroke is a common problem in pets during the summer months, especially in hot, humid climates. This life-threatening condition can affect dogs of any age, breed, or gender.
Heatstroke in dogs is defined as a nonpyrogenic increased body temperature above 104°F (40°C), with a spectrum of systemic signs.1 The ability to rapidly recognize and begin treatment of heatstroke is vital to maximize the chances of saving the animal’s life.
Maintenance of normal body temperature is an important aspect of preserving homeostasis and preventing interruption of normal metabolism.
The thermoregulatory center, located in the anterior hypothalamus, maintains body temperature within a narrow range, or set point. A pyrogenic hyperthermia, or fever, may be induced by an increase in the set point in response to disease.
Differentiating between pyrogenic and nonpyrogenic hyperthermia is important, due to the variation in pathophysiology and treatment of each disease process.
If a dog develops pyrogenic hyperthermia, the underlying cause guides treatment. Active cooling of a patient with pyrogenic hyperthermia causes metabolic stress and physical discomfort.2
In one human study, pyrogenic hyperthermia was induced via an injection of IL-2, a pyrogenic cytokine; then subjects were actively cooled, resulting in an increase in oxygen consumption and reported physical discomfort. Within that study, pyrogenic hyperthermia subjects exposed to forced air warming were most comfortable.2
A nonpyrogenic hyperthermia, such as heatstroke, is not due to a change in the hypothalamic thermoregulatory set point, which allows us to perform active cooling without the consequences previously mentioned.
A minimum nonpyrogenic body temperature elevation of 1.8°F (1°C) can activate heat receptors found in the periphery, triggering the thermoregulatory center, which in turn induces constriction of renal and splanchnic vessels, tachycardia, and cutaneous vasodilation. These processes result in increased blood flow to the skin, where it can be cooled.1
The hypothalamus also stimulates tachypnea and panting to assist with cooling.1
Heat-related illness can vary in severity and, in humans, is classified based on that severity.
Heat stress is rarely recognized in veterinary patients. It includes some discomfort and physiologic strain. The core body temperature will be normal.3
Heat cramps are rarely recognized in veterinary patients. Muscle cramps occur secondary to the depletion of sodium and water. The core body temperature will be normal.3,4
Heat exhaustion includes weakness, ataxia, fainting, and an inability to continue the work the person was performing. The core body temperature will be normal or slightly increased.3,4
Heat stroke includes dysfunction of the central nervous system, hypovolemia, and cellular dysfunction. The core body temperature will be elevated.3,4
TYPES OF HEATSTROKE
Heatstroke is classified as exertional or nonexertional (classical).
Exertional heatstroke occurs during exercise and is more common in dogs that have not been acclimated to their environment. If a period of temperature acclimation is allowed, dogs become less susceptible to heatstroke. Acclimation can take up to 60 days, although the animal is partially acclimated within 10 to 20 days.3
While exertional heatstroke can occur in working dogs, it is less common because handlers are typically more knowledgeable. For example, it is possible for military dogs to work in environmental temperatures reaching 140°F (60°C) without adverse effects. After racing, greyhounds can transiently have rectal temperatures as high as 107.6°F (42°C) without showing signs of heatstroke.4
Nonexertional heatstroke results from exposure to increased environmental temperature in the absence of adequate means of cooling. This may be seen when a dog is enclosed in a parked car or left in a yard without shade and water.
Several predisposing factors may decrease a dog’s ability to cool itself; therefore, increasing its risk for developing heatstroke. These factors are listed in Table 2. Dogs that have a history of heatstroke are more susceptible to developing it again.4
|Table 2. Examples of Factors That Predispose Dogs to Heatstroke|
The acute-phase response is a coordinated cellular response that occurs in inflammatory events, such as infection, surgery, trauma, burns, immune-mediated diseases, and nonpyrogenic hyperthermia.3,5 During nonpyrogenic hyperthermia, this response is stimulated in an attempt to protect tissues from excessive heat and promote repair.3
Acute-phase proteins are divided into 2 categories:
- Negative acute-phase proteins decrease by 25% during an acute-phase response.5,6In most species, albumin is a negative acute-phase protein, and levels may decrease during an acute-phase response due to gastrointestinal (GI) or renal loss or decreased production.
- Positive acute-phase proteins increase by 25% during an acute-phase response.5,6In dogs, positive acute-phase proteins include C-reactive protein and serum amyloid A.
- C-reactive protein activates the complement system, which promotes phagocytosis, and up- or down-regulates cytokine production and chemotaxis.
- Serum amyloid A causes chemotaxis of several types of white blood cells and inhibits inflammation.6
Several other acute-phase proteins play important roles in the acute-phase response, including:6
- Haptoglobin: Reduces oxidative damage
- Ceruloplasmin: Scavenges free radicals
- Fibrinogen: Plays a role in tissue repair.
The acute-phase response also initiates production of heat shock proteins (HSPs).7
Heat Shock Proteins
When cells are exposed to an increased temperature, HSPs protect against protein denaturation.8 They prevent disaggregation of denatured proteins, refold denatured proteins, protect against endotoxin leakage across the intestines, and reduce cerebral ischemia.7
Effects by Body System
Heatstroke has multiple deleterious effects within the body (Table 3). Direct cytotoxicity occurs at body temperatures ranging from 106.7°F to 107.6°F (41.5°C—42°C). At these temperatures enzymes and proteins are denatured.1 The severity of these effects depends on both degree of body temperature elevation and duration of time it is elevated.
|Table 3. Heatstroke Effects by Body System|
|BODY SYSTEM||HEATSTROKE EFFECTS|
Figure 1. Petechial hemorrhage on (A) the abdominal wall, and (B) the ear pinna of a young pug with disseminated intravascular coagulation caused by heatstroke. Brachycephalic breeds are particularly at risk for heatstroke because of limited ability to thermoregulate as a result of partial upper airway obstruction.
Figures 1-3 courtesy of Dr. Lesley G. King
Pathologic findings in dogs with heatstroke are extensive and severe. Necropsy of 11 dogs with fatal heatstroke revealed severe pulmonary edema, splenomegaly, and hepatomegaly. Hemorrhage was observed within the myocardium, peritoneum, mesentery, and throughout the GI tract. The brains of 9 dogs had edema and necrosis. The kidneys in all 11 dogs revealed lesions, glomerular congestion, and tubular degeneration and necrosis. The small intestine of 2 dogs, large intestine of another, and liver of a third could not be examined due to autolysis.9
History & Clinical Signs
History often includes recent exercise or confinement in an area without access to water or shade.
The most common clinical signs in one study were collapse, tachypnea, shock, inappropriate mentation, and signs of coagulopathy,10 but may also include tachycardia, hyperemia, and hyperdynamic to nonexistent pulses. Concurrent central nervous system (CNS) signs can range from slight ataxia to seizures or coma.
Damage to the GI tract quickly leads to severe diarrhea. The diarrhea is often bloody (hematochezia) when it comes from the lower GI tract, or it may be black (melena) if originating from the upper GI tract.
Although hyperthermia is usually present, a patient with heatstroke may present normothermic or hypothermic due to cooling efforts prior to arrival at the hospital, a prolonged travel time to the hospital, or secondary to shock.
Common Diagnostic Findings
Upon presentation, perform a urinalysis and blood analysis, including:
- Serum biochemical profile, including electrolytes, blood glucose, and lactate
- Complete blood count and differential (manual)
- Coagulation panel, including prothrombin time (PT) and activated partial thromboplastin time (aPTT).
Common findings in patients with heatstroke are listed in Table 4.
|Table 4. Clinicopathologic Findings: Heatstroke Patients|
|Serum Biochemical Profile10|
||May be increased
||May be increased
||May be increased
||Hepatic injury, rhabdomyolysis (due to direct thermal damage to muscle or increased muscular activity)10
||May be increased
||Renal (direct thermal damage, myoglobinuria due to rhabdomyolysis) and prerenal azotemia (dehydration, vasoconstriction)10
||May be increased
||Rhabdomyolysis (due to direct thermal damage to muscle or increased muscular activity)10
||May be observed
||Increased use (due to increased ATP demand) or decreased production (due to hepatic damage) of blood glucose10
|Lactate||May be increased||Hypovolemia and decreased perfusion leading to tissue hypoxia10|
|Complete Blood Cell Count & Differential10|
||Secondary to platelet consumption (caused by GI hemorrhage) and platelet aggregation (due to disseminated intravascular coagulation).10
|Packed cell volume
|Nucleated red blood cells||May be observed||Secondary to direct thermal damage to bone marrow causing premature release of cells10|
|Activated partial thromboplastin time
||May be prolonged
||Direct thermal injury to endothelium and consumption of coagulation factors10
|Prothrombin time||May be prolonged||Direct thermal injury to endothelium and consumption of coagulation factors|
Implementing treatment as soon as possible—even before the patient reaches the hospital—significantly improves the patient’s prognosis.
Active cooling is the most important aspect of treatment, although it may not prevent deleterious effects of heatstroke. If possible, instruct the owner to begin cooling his or her dog during travel to the hospital. One study revealed dogs actively cooled before arriving at the hospital had a lower mortality rate (19%) than dogs not cooled prior to arrival (49%).11
What to AVOID During Treatment
Avoid use of ice as it causes peripheral vasoconstriction, preventing cooling of blood via shunting to the periphery.14 Ice may also damage the skin and make treatment uncomfortable for the patient.
Avoid gastric lavage or cold water enemas, if possible. The risk of aspiration may outweigh the benefits of gastric lavage, and cold water enemas may further damage the already compromised GI tract.15
Avoid shivering in the patient; however, one human study states that shivering does not contribute to hyperthermia because the heat produced is minor relative to the amount of cooling achieved during emergency treatment for heatstroke.15
The goal of active cooling is to return the dog to a normal body temperature, while avoiding further organ damage.12 An effective cooling method that combines evaporative and convective cooling is directing a fan toward the dog and applying cool or tepid water to the skin. Monitor the temperature every 5 minutes and, once body temperature reaches 103.5°F to 104°F (39.7°C—40°C), discontinue active cooling in order to avoid rebound hypothermia.1
In addition to active cooling, evaluate the airway for patency and, if necessary, intubate the patient or perform an emergency tracheostomy. Provide supplemental oxygen via a mask or flow-by for dogs that are breathing unassisted. Note that older oxygen cages that do not have temperature and humidity controls may exacerbate hyperthermia.13
Intravenous fluids are considered a cornerstone of heatstroke treatment.
Upon arrival, establish IV access in the patient and administer room temperature crystalloids.1 A bolus of crystalloids is beneficial for hypovolemic and hemoconcentrated heatstroke patients. Crystalloids provide cardiovascular support by expanding intravascular volume, and increasing blood flow to the periphery, aiding with the cooling process. Once hospitalized, crystalloids should be continued to provide maintenance fluid therapy as well as replace continuous losses (seen with continued vomiting and diarrhea).
If crystalloids do not adequately maintain intravascular volume, consider administering colloids.1 Colloids may also be considered if the patient is hypoalbuminemic.1,13,14 Fresh frozen plasma is recommended if the patient has prolonged PT and/or aPTT.
Antibiotics. Due to the high risk of bacterial translocation secondary to GI damage, consider broad-spectrum antibiotics (Table 5), while keeping the possibility of antibiotic resistance in mind.13 Once antibiotic therapy is initiated, continue until GI signs, such as hematochezia, melena, or hematemesis, resolve and the patient is eating.14
GI tract support. Antiemetics (metoclopramide, dolasetron, maropitant) are beneficial when GI tract damage or CNS abnormalities cause nausea. Administer GI protectants because GI ulceration is likely to occur. Proton pump inhibitors (omeprazole, pantoprazole) are beneficial to prevent or treat gastric ulceration, while famotidine acts as an H2 receptor antagonist and also decreases the production of acid. Sucralfate is given orally and acts as a local protectant that binds to ulcers preventing further damage from acid, pepsin, or bile (Table 5).
CNS support. CNS abnormalities are common in heatstroke patients. In some cases, these abnormalities may result from increased intracranial pressure.
Mannitol—an osmotic diuretic that expands intravascular volume, decreases blood viscosity and intracranial pressure, and improves cerebral microcirculation—can be administered if the patient has neurologic signs (Table 5).1 If mannitol is contraindicated (such as with dehydration, intracranial hemorrhage, pulmonary edema, or anuria secondary to renal disease) hypertonic saline (7.2%—7.5%) can be used instead. Hypertonic saline will increase cerebral, coronary, and microvascular blood flow as well as decrease intracranial pressure. As with mannitol, hypertonic saline is contraindicated with dehydration.1
Additional nursing management of patients with suspected cerebral edema may include elevation of the head and avoidance of compression of the jugular veins.
Cardiac support. Ventricular arrhythmias are common in patients presenting with heatstroke because cardiac cells are susceptible to thermal injury and ischemia. Damage to the myocardium causes defects in conduction leading to ventricular arrhythmias, which can be treated with lidocaine.4
|Table 5. Medical Therapy for Canine Heatstroke Patients|
||20—40 mg/kg IV Q 8 H
||First generation cephalosporin
||22 mg/kg IV Q 8 H
||5—20 mg/kg IV, IM, PO (once discharged) Q 24 H or divided Q 12 H
|Metronidazole||Antibacterial and antiprotozoal||10—15 mg/kg IV, PO (once discharged) Q 12 H|
||Antiemetic (5-HT3 antagonist)
||1 mg/kg IV Q 24 H
||0.5 mg/kg IV, IM, PO (once discharged) Q 12—24 H
||Antiemetic (NK1 receptor agonist)
||1 mg/kg/day SC or IV, 2 mg/kg/day PO (once discharged)
||1—2 mg/kg/day IV as a CRI
||Proton pump inhibitor
||1 mg/kg PO (once discharged) Q 24 H
||Proton pump inhibitor
||1 mg/kg IV Q 24 H
||0.5—2 mg/kg IV, IM, PO (once discharged) Q 8—12 H
|Sucralfate||Gastric protectant||Small dog: 0.25 g PO Q 8 H
Medium dog: 0.5 g PO Q 8 H
Large dog: 1 g PO Q 8 H
|Increased Intracranial Pressure
||0.25—0.5 g/kg IV slowly over 20 minutes
||Class 1B antiarrhythmic
||2 mg/kg bolus IV, then 40—80 mcg/kg/min CRI
|Cardiovascular Support||Dopamine||Catecholamine||3—15 mcg/kg/min CRI|
|Adapted from Plumb DC. Veterinary Drug Handbook, 4th ed. White Bear Lake, MN: PharmVet Publishing, 2002.|
Initiate patient monitoring upon arrival, including:
- Baseline vital signs (heart rate, respiratory rate and effort, temperature, mucous membrane color, and capillary refill time)
- Blood pressure
- Electrocardiography (ECG)
- Pulse oximetry.
Although unlikely to be seen on presentation, multiple organ dysfunction syndrome (MODS) may develop during hospitalization. MODS occurs when 2 or more systems are affected and begin to fail. Because heatstroke affects multiple organ systems, the risk for developing MODS is high, and the patient should be monitored closely during hospitalization.
Placement of a urinary catheter and monitoring of urine production is beneficial in patients with renal insufficiency or failure.14 Normal urine output in a dog on IV fluids is at least 1 to 2 mL/kg/hour. A decrease in urine output may be due to renal failure, hypovolemia, or hypotension. If unable to place a urinary catheter, the patient’s urination should be monitored closely.
Nutritional support is beneficial for the GI system. It improves the GI tract’s integrity and allows the patient to replace important proteins, electrolytes, and other nutrients. If the patient is not willing to eat, a nasoesophageal feeding tube can be placed to allow for trickle feeding.14
Serial monitoring during hospitalization should include:
- Neurologic status assessment
- Heart rate, pulse quality, respiratory rate and effort, blood pressure, and ECG
- PT and aPTT
- Packed cell volume and total protein
- Blood glucose and electrolytes
- Lactate and acid—base balance
- Urine output.
Response to therapy can be monitored, in part, with serial lactate tests because lactate clearance is associated with resolution of tissue hypoxia.1
Prognosis is most dependent on length of time the patient was hyperthermic and highest body temperature experienced. When the body temperature reaches 109.4°F (43°C), marked organ damage and high mortality are seen. Cellular necrosis and destruction of all cellular structures occurs once body temperature has been maintained between 120.2°F to 122°F (49°C—50°C) for only 5 minutes.1
Probability of survival increases with decreased time period of hyperthermia; however, it is important to monitor the patient for MODS and coagulopathies.12 Negative indicators of prognosis associated with higher mortality include:
- Development of ventricular arrhythmias1
- Severe coagulopathies10
- Abnormal neurologic signs that do not resolve once body temperature normalizes.
In humans, 20% of heatstroke victims suffer unresolved brain damage and CNS abnormalities, which have been linked to high mortality rates.12 Therefore, return of normal CNS function is considered a positive prognostic indicator for dogs that have suffered heatstroke.
Prevention of heatstroke relies heavily on owner education. Owners can prevent heatstroke several ways:
- Ensure availability of adequate shade and drinking water outdoors
- Exercise dogs only during cooler periods of the day
- Never leave dogs alone in closed vehicles
- Acclimate dogs to warm temperatures for up to 2 months
- Surgically address upper airway obstructions, such as brachycephalic airway disease or laryngeal paralysis, to decrease risk in individual susceptible patients.
aPTT = activated partial thromboplastin time; CNS = central nervous system; ECG = electrocardiography; GI = gastrointestinal; HSP = heat shock protein; MODS = multiple organ dysfunction syndrome; PT = prothrombin time
- Johnson SI, McMichael M, White G. Heatstroke in small animal medicine: A clinical practice review. J Vet Emerg Crit Care 2006; 16(2):112-119.
- Cannon JG. Perspective on fever: The basic science and conventional medicine. Complement Ther Med 2013; 21:S54-S60.
- Hemmelgarn C, Gannon K. Heatstroke: Thermoregulation, pathophysiology, and predisposing factors. Compend Contin Educ Pract Vet 2012; 35(7):E4.
- Fluornoy WJ, Hepler D. Heatstroke in dogs: Pathophysiology and predisposing factors. Compend Contin Edu Pract Vet 2003; 25(6):410-418.
- Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. NEJM1999; 340(6):448-454.
- Cray C, Zaias J, Altman NH. Acute phase response in animals: A review. Comp Med 2009; 59(6):517-526.
- Epstein Y, Roberts WO. The pathophysiology of heat stroke: An integrative view of the final common pathway. Scand J Med Sci Sport 2011; 21(6):742-748.
- Wu X, Zhang Y, Yin Y, et al. Roles of heat-shock protein 70 in protecting against intestinal mucosal damage. Front Biosci (Landmark Ed) 2013; 18:356-365.
- Bruchim Y, Loeb E, Saragusty J, Aroch I. Pathological findings in dogs with fatal heatstroke. J Comp Pathol 2009; 140(2-3):97-104.
- Bruchim Y, Klement E, Saragusty J, et al. Heat stroke in dogs: A retrospective study of 54 cases (1999-2004) and analysis of risk factors for death. J Vet Intern Med 2006; 20(1):38-46.
- Drobatz KJ, Macintire DK. Heat-induced illness in dogs: 42 cases (1976-1993). JAVMA 1996; 209(11):1894-1899.
- Bouchama A, Knochei JP. Heat Stroke. NEJM 2002; 346(25):1978-1988.
- Fluornoy W, Wohl JS, MacIntire D. Heatstroke in dogs: Clinical signs, treatment, prognosis, and prevention. Compend Contin Edu Pract Vet 2003; 25(6):422-431.
- Hemmelgarn C, Gannon K. Heatstroke: Clinical signs, diagnosis, treatment, and prognosis. Compend Contin Educ Pract Vet 2013; 35(7):E3.
- Hadad E, Rav-Acha M, Heled Y, et al. Heat stroke: A review of cooling methods. Sports Med 2004; 34(8):501-511.